AKTX
Price
$1.09
Change
-$0.03 (-2.68%)
Updated
Jul 28, 12:11 PM (EDT)
Capitalization
36.04M
KPRX
Price
$2.94
Change
-$0.05 (-1.67%)
Updated
Jul 28, 01:02 PM (EDT)
Capitalization
9.1M
Interact to see
Advertisement

AKTX vs KPRX

Header iconAKTX vs KPRX Comparison
Open Charts AKTX vs KPRXBanner chart's image
Akari Therapeutics
Price$1.09
Change-$0.03 (-2.68%)
Volume$300
Capitalization36.04M
Kiora Pharmaceuticals
Price$2.94
Change-$0.05 (-1.67%)
Volume$125
Capitalization9.1M
AKTX vs KPRX Comparison Chart in %
Loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKTX vs. KPRX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a Hold and KPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (AKTX: $1.12 vs. KPRX: $2.99)
Brand notoriety: AKTX and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 44% vs. KPRX: 5%
Market capitalization -- AKTX: $36.04M vs. KPRX: $9.1M
AKTX [@Biotechnology] is valued at $36.04M. KPRX’s [@Biotechnology] market capitalization is $9.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileKPRX’s FA Score has 2 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • KPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, KPRX is a better buy in the long-term than AKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 2 TA indicator(s) are bullish while KPRX’s TA Score has 4 bullish TA indicator(s).

  • AKTX’s TA Score: 2 bullish, 4 bearish.
  • KPRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KPRX is a better buy in the short-term than AKTX.

Price Growth

AKTX (@Biotechnology) experienced а -0.88% price change this week, while KPRX (@Biotechnology) price change was -5.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +21.29%, and the average quarterly price growth was +47.53%.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKTX($36M) has a higher market cap than KPRX($9.1M). AKTX YTD gains are higher at: -8.197 vs. KPRX (-9.394). KPRX has higher annual earnings (EBITDA): -9.57M vs. AKTX (-17.63M). KPRX has more cash in the bank: 24.1M vs. AKTX (2.58M). KPRX has less debt than AKTX: KPRX (159K) vs AKTX (1.85M). AKTX (0) and KPRX (0) have equivalent revenues.
AKTXKPRXAKTX / KPRX
Capitalization36M9.1M396%
EBITDA-17.63M-9.57M184%
Gain YTD-8.197-9.39487%
P/E RatioN/A3.67-
Revenue00-
Total Cash2.58M24.1M11%
Total Debt1.85M159K1,161%
FUNDAMENTALS RATINGS
AKTX vs KPRX: Fundamental Ratings
AKTX
KPRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
8783
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (22) in the Pharmaceuticals Other industry is somewhat better than the same rating for AKTX (82) in the Pharmaceuticals Major industry. This means that KPRX’s stock grew somewhat faster than AKTX’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as AKTX (100) in the Pharmaceuticals Major industry. This means that KPRX’s stock grew similarly to AKTX’s over the last 12 months.

KPRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as AKTX (99) in the Pharmaceuticals Major industry. This means that KPRX’s stock grew similarly to AKTX’s over the last 12 months.

KPRX's Price Growth Rating (83) in the Pharmaceuticals Other industry is in the same range as AKTX (87) in the Pharmaceuticals Major industry. This means that KPRX’s stock grew similarly to AKTX’s over the last 12 months.

KPRX's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as AKTX (8) in the Pharmaceuticals Major industry. This means that KPRX’s stock grew similarly to AKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKTXKPRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEG23.440.32
+1.38%
Montrose Environmental Group
SMFG16.23-0.01
-0.06%
Sumitomo Mitsui Financial Group
NVMI258.62-2.96
-1.13%
Nova Ltd
FEMY0.90-0.02
-1.66%
Femasys
LCTX1.13-0.02
-1.74%
Lineage Cell Therapeutics

AKTX and

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
+1.82%
KPRX - AKTX
30%
Poorly correlated
-1.97%
CRVO - AKTX
24%
Poorly correlated
+11.55%
DSGN - AKTX
23%
Poorly correlated
-0.50%
RNAC - AKTX
23%
Poorly correlated
-0.97%
ALLR - AKTX
23%
Poorly correlated
N/A
More

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if KPRX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-1.97%
NCNA - KPRX
90%
Closely correlated
+10.37%
RNAC - KPRX
89%
Closely correlated
-0.97%
NBY - KPRX
89%
Closely correlated
+3.23%
WINT - KPRX
89%
Closely correlated
-3.92%
AGEN - KPRX
88%
Closely correlated
-1.32%
More